Cosmos Health Negotiates €25 Million Financing and Reduces Warrant Overhang by 38%

Cosmos Health announced a series of financial updates on Tuesday, including ongoing negotiations for up to €25 million in financing from the European Investment Bank and the elimination of 38% of its outstanding warrant overhang without diluting shareholder equity. The company also stated that it has identified no internal business developments to account for the recent decline in its share price and reaffirmed its current growth projections.

The proposed financing agreement with the European Investment Bank aims to provide the company with additional capital to support its operations. Regarding the warrant reduction, the company successfully removed a significant portion of its warrant overhang, a move designed to simplify its capital structure. Despite the recent downward trend in the company’s stock market valuation, management reported that its operational performance remains consistent with its previously stated growth trajectory. The company maintains that its internal business activities do not correlate with the recent volatility observed in its share price.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI